Screening
Mass screening for hepatitis C by means of hepatitis C antibody testing does not appear to be a cost-effective strategy. However, an abstract presented at the AASLD meeting in October reported that alanine aminotransferase screening for chronic hepatitis C is cost- effective in individuals between 15 and 58 years of age (ie, across broad age groups). Improvements in cost efficiency may be obtained through identification of risk factors for HCV prior to screening.
Saturday, September 12, 2009
Hepatitis Cost Effectiveness
Subscribe to:
Post Comments (Atom)
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
ReplyDeleteliver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers